Autoimmune Basis for Postural Tachycardia Syndrome

Status Recruiting

Clinical Trial Summary

The purpose of this study is to test the hypothesis that an antibody-mediated autoimmune reaction will cause symptoms of autonomic dysfunction in some patients with postural tachycardia syndrome (POTS). The investigators further hypothesize that electrical stimulation of the vagus nerve will improve POTS symptoms, autoimmunity and inflammation.

Clinical Trial Description

The present study is designed to test the hypothesis that muscarinic autoantibody-mediated parasympathetic dysfunction contributes to the pathogenesis of POTS, and that parasympathetic (vagal) stimulation improves POTS symptoms, autoimmunity and inflammation. Define and determine the prevalence, burden, and clinical significance of muscarinic autoantibodies in a well-phenotyped cohort of POTS patients with and without gastroparesis and a matched cohort of healthy control subjects. Evaluate the impact of vagal stimulation on antibody suppression, inflammatory inhibition, and symptom improvement in POTS patients. Non-invasive transcutaneous stimulation of the auricular branch of the vagus nerve (tragus stimulation) will be used to increase parasympathetic activity. ;

Study Design

Related Conditions & MeSH terms

Postural Orthostatic Tachycardia Syndrome
Postural Tachycardia Syndrome
Syndrome
Tachycardia

Clinical Trial Details

NCT number	NCT05043051
Study type	Interventional
Source	University of Oklahoma
Contact	Xichun Yu
Phone	405-271-5896
Email	xichun-yu@ouhsc.edu
Status	Recruiting
Phase	N/A
Start date	January 14, 2022
Completion date	July 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03124355` - Vagal Stimulation in POTS	Phase 1
Recruiting	`NCT04310644` - Autonomic Small Fiber Neuropathy and Ehlers Danlos Syndromes - Prospective Study and Registry
Completed	`NCT03253120` - Alterations of Attention in POTS Depending on Body Position and Hydration	N/A
Completed	`NCT03919773` - IVIG (Gamunex-C) Treatment Study for POTS Subjects	Phase 1/Phase 2
Active, not recruiting	`NCT01988883` - Modafinil and Cognitive Function in POTS	Early Phase 1
Active, not recruiting	`NCT01000350` - Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)	N/A
Recruiting	`NCT00409435` - A Study of Pyridostigmine in Postural Tachycardia Syndrome	Phase 2
Completed	`NCT00770484` - Effect of Exercise in OI	N/A
Completed	`NCT00581022` - Objective Sleep Disturbances in Orthostatic Intolerance
Terminated	`NCT00748228` - Dopamine in Orthostatic Tolerance	N/A
Active, not recruiting	`NCT05630040` - VNS for Long-COVID-19	N/A
Recruiting	`NCT04632134` - Long-term Effects of Transcutaneous Vagal Nerve Stimulation on Postural Orthostatic Tachycardia Syndrome (POTS)	N/A
Completed	`NCT00685919` - Peripheral Dopamine in Postural Tachycardia Syndrome	Phase 2/Phase 3
Completed	`NCT00061009` - Hypnosis in Autonomic Function	N/A
Recruiting	`NCT05618054` - Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?	N/A
Completed	`NCT01366963` - Cognitive Dysfunction in Postural Tachycardia Syndrome	N/A
Recruiting	`NCT05107635` - Inappropriate Sinus Tachycardia Registry
Terminated	`NCT02154009` - Clinical Autonomic Disorders: A Training Protocol
Completed	`NCT03602482` - Standing Cognition and Co-morbidities of POTS Evaluation	N/A
Completed	`NCT02167412` - EEG Characteristics in Youth POTS and/or Syncope